Turing Pharmaceutical News Today

As gene sequencing, machine learning, powerful imaging, sensors, gene and cell therapies make their way out of academic labs into everyday healthcare, our approach to healthcare is changing. For the first time, not only can we pinpoint the molecular and genetic causes of disease, but we also have the technologies to access them. On the back of this, prevention and cures are becoming possible. Can we afford them?

While major pharmaceutical companies have always been derided for considering profits over the well-being of the general population, even earning the moniker of "Big Pharma" denoting a shadow organization...

The notorious former Turing Pharmaceuticals boss served a little more than half of his seven-year sentence.

Commentary  As inflation rates soar toward 8 percent in the United States, many are feeling the squeeze and will ...

The patent system in pharmaceuticals incentivizes firms to game the system for monopoly profits

Judge Denise Cote of New York’s Southern District upheld Martin Shkreli’s exile from the industry and clarified exactly what sort of actions the former CEO is barred from taking part in. Shkreli is not only prohibited from working in biopharma—he can’t talk to industry friends or wax poetic about it on his blog, either, Cote said in a 10-page opinion filed Friday.

By Ryan Steal Martin Shkreli, the recently convicted pharma tycoon, must’ve been high on his own supply of a substance on this date in hip hop history in 2016. This is because his possession of Wu-Tang Clan’s one-of-a-kind, $2 million Once Upon A Time In Shaolin record gave him the impression he was ‘badder’ than […]

Disgraced pharmaceutical executive Martin Shkreli has been jailed for defrauding investors in two failed hedge funds. Shkreli, known for hiking up the price of a life-saving drug, cried in court.

When last we checked in with Martin Shkreli -- founder of Turing Pharmaceuticals and the personification of everything that's wrong...

President Joe Biden wanted to lower Medicare drug spending, Big Pharma’s Democratic...